Latest Industry News & Trends

Ophthalmic Company Revenue Down 1.8 Percent in Q4-2025; Seven Firms See Declines

Ophthalmic manufacturer revenue in Q4-2025 totaled $11.8 billion. Revenue decreased 1.8 percent from the same quarter in 2024 and increased 2.5 percent from Q3-2025. The total includes Market Scope...

Science Corp. Leads Latest Fundraising with $230 Million in Series C

Science Corporation led recent ophthalmic fundraising efforts with $230 million in a Series C round to support its Prima implant for dry age-related macular degeneration. Financing announced in the...

Weekly Poll of MDs and ODs, March 2026

Super Vision Gains China Approval of i-NYS Implant for Congenital Nystagmus

China-based Super Vision reported March 16 that its i-NYS implantable device forcongenital nystagmus had received market approval from China’s National Medical Products Administration (NMPA). Super...

EU-India Free Trade Agreement to Phase in Lower Pharma and Device Tariffs

A free trade agreement reached Jan. 27 by the European Union and India will reduce or eliminate tariffs on about 90 percent of goods, including pharmaceuticals and medical devices, between the two ...

EU-India Free Trade Agreement to Phase in Lower Pharma and Device Tariffs

A free trade agreement reached Jan. 27 by the European Union and India will reduce or eliminate tariffs on about 90 percent of goods, including pharmaceuticals and medical devices, between the two ...

2025 in Review: Alcon Launches Two New Platforms, Unity and Voyager

Ophthalmic industry leader Alcon launched the Unity Vitreoretinal Cataract System (VCS) and Unity Cataract System (CS) in April 2025. The devices are designed to replace Alcon’s Constellation dual-...

Meibum Scientific Appoints Ryan S. Bleeks as Interim CEO

Meibum Scientific, of Brentwood, Tennessee, announced Dec. 2 that it had appointed Ryan S. Bleeks as interim chief executive officer to lead the commercialization of dry eye treatment devices Bleph...

Dry Eye Device Field Gets More Crowded With Product Launches

The dry eye procedure market is relatively small, but barriers to entry are low, and that is attractive for new competitors. Asian companies, from China and South Korea, launched new machines in th...

Iantrek Announces US Commercial Launch of AlloFlo Uveo Biostent for Glaucoma

Iantrek announced Oct. 14 the US commercial launch of the AlloFlo Uveo, a novel minimally invasive glaucoma surgical (MIGS) device targeting the uveoscleral drainage pathway. The AlloFlo Uveo allog...

US FDA Gives Green Light to Trial of Avisi’s VisiPlate Aqueous Shunt for Glaucoma

Avisi Technologies announced Oct. 14 that the US FDA had signed off on its investigational device exemption (IDE) submission, allowing the company to proceed with a trial of the VisiPlate aqueous s...

Euretina Presentations Included Surprises on Vitreous Cutters, PBM Treatment

Doctors who attend the annual Euretina congress often hear paper presentations similar to those at the American Society of Retina Specialists meeting, but sessions also provide important difference...

First Patient Treated in US Trial of Eyetronic Optic Nerve Therapy for Glaucoma

The Glaucoma Center of San Francisco announced July 21 that it had treated the first patient in the US as part of a clinical trial of Eyetronic, a non-invasive therapy to stimulate the optic nerve....

Alcon to Acquire LumiThera and Its Photobiomodulation Device for Dry AMD

Alcon announced July 7 that it intended to acquire LumiThera and its photobiomodulation (PBM) device that targets early and intermediate dry age-related macular degeneration (AMD). No financial det...

Malvina Eydelman, MD, Named CEO of CCOI Organization

Longtime US FDA regulator and board-certified ophthalmologist Malvina Eydelman, MD, has stepped into a new role as chief executive officer of the Collaborative Community on Ophthalmic Innovation (C...

Malvina Eydelman, MD, Named CEO of CCOI Organization

Longtime US FDA regulator and board-certified ophthalmologist Malvina Eydelman, MD, has stepped into a new role as chief executive officer of the Collaborative Community on Ophthalmic Innovation (C...

Retina Surgeons Ready for Alcon to Make a Splash with Unity VCS

Alcon looks ready to shake up the retinal treatment device market with the launch of the Unity VCS later in 2025. Anytime the world’s number one manufacturer of vitreoretinal surgical systems intro...

2024 in Review: Corporate and Surgeon Rankings of Top 10 Stories

Market Scope asked industry participants and surgeons to select the top story for 2024. Below are their choices. Zeiss’ Rollout of Micor 700 Shakes Up Cataract Equipment Market in US MAC Turmoil Sh...

2024 in Review: LumiThera’s Valeda is First Treatment for Early, Intermediate Dry AMD

The US FDA granted market authorization to LumiThera’s Valeda Light Delivery System as a de novo device on Nov. 4, making it the first treatment of any kind, device or drug, to receive the FDA’s ba...

EssilorLuxottica to Acquire Ophthalmic Device Maker Espansione Group

Eyewear conglomerate EssilorLuxottica announced Dec. 16 that it had entered into an agreement to acquire Espansione Group, an Italian maker of light-based ophthalmic devices. Financial details and ...

Low-Vision Devices, Including One Similar to a Fly’s Eye, Highlighted at CES 2025

The 2025 Consumer Electronics Show featured at least two wearable devices intended to improve vision for those who are vision impaired or legally blind. The conference was held Jan. 7-10 in Las Veg...

EssilorLuxottica to Acquire Espansione Group, Maker of Ophthalmic Devices

Eyewear conglomerate EssilorLuxottica announced Dec. 16 that it had entered into an agreement to acquire Espansione Group, an Italian maker of light-based ophthalmic devices. Financial details and ...